While the reforms are less ambitious than what progressives wanted, they could still have a significant impact on costs.
Beginning next year, the law will also require drug companies to pay Medicare a rebate if they raise their drug prices at a faster rate than inflation. Additionally, the law will limit monthly insulin cost-sharing to $35 for people with Medicare Part D starting in 2023.
The Inflation Reduction Act essentially duplicates the language of Medicaid’s inflation rebate law, making Medicare now vulnerable to the same loopholes.that “it’s going to be really hard to reverse” the drug price reforms once they take effect and begin having a material impact.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Big Pharma and GOP Allies Aim to Sabotage Medicare Drug Price Reforms'All the contributions they make and all their lobbying money gives them a lot of power,' Democratic Rep. Peter Welch said of the pharmaceutical industry.
Lire la suite »
Big Pharma and GOP Allies Aim to Sabotage Medicare Drug Price ReformsThe pharmaceutical industry and its Republican allies in Congress are openly signaling their plans obstruct at every turn as the Biden administration looks to begin implementing a recently passed law that will allow Medicare to negotiate drug prices for the first time in its history.
Lire la suite »
Incoming GOP House Majority Could End Big Oil Investigation, Advocates WarnThe incoming chair of the House Oversight Committee, Republican Rep. James Comer, has openly bashed the investigation.
Lire la suite »
CFP Semifinal Features No. 3 TCU's Big 12 Speed vs. No. 2 Michigan's Big 10 PowerIt’s tempting to boil down the Fiesta Bowl matchup to Big Ten power vs. Big 12 speed on each side of the ball. Both sides think that’s an oversimplification.
Lire la suite »
DOJ sues pharma giant AmerisourceBergen Corp. for allegedly helping to fuel the opioid epidemicThe Justice Department is suing AmerisourceBergen Corp., accusing the pharmaceutical giant of helping fuel the opioid epidemic by allegedly repeatedly failing to report suspicious orders of opioids for nearly a decade.
Lire la suite »
Feds accuse pharma giant of drug law violations that fed opioid epidemicThe Department of Justice highlighted the actions of pharmacies to illustrate their accusations against AmerisourceBergen.
Lire la suite »